Genome Medicine


Musings

Musings on genome medicine: cholesterol and coronary artery disease

David G Nathan* and Stuart H Orkin

Author Affiliations

Dana-Farber Cancer Institute, Binney Street, Boston, MA 02115, USA


For all author emails, please log on.

Genome Medicine 2009, 1:60 doi:10.1186/gm60

Published: 8 June 2009

Abstract

Cholesterol levels and not inflammatory markers are the major variables that pose a risk of coronary artery disease. Diabetes greatly increases the risk at any cholesterol level. Coronary artery disease and cancer are linked by a common protein - an apoptotic protein that also functions as a regulator of insulin secretion.